Junbo Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junbo Ge has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Aijun Sun
Institute of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, PR China
3 shared publications - Jason M. Lazar
Division of Cardiovascular Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA
3 shared publications Keqiang Wang
Department of Cardiology , Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases , Shanghai 200032 , China
3 shared publications- Xian-Cheng Jiang
Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, USA
3 shared publications - Xueying Chen
Institute of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, PR China
3 shared publications - Yunzeng Zou
Institute of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, PR China
3 shared publications
Latest Publications
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (8) , 7155-7168
Short-term prognosis of patients in different stages of severe tricuspid regurgitation after transcatheter tricuspid-valve replacement
Background: The tricuspid regurgitation (TR) syndrome, based on the extent of cardiac and extracardiac involvement, is a newly proposed staging method to evaluate the progression of TR. This study aimed to explore cardiac structural characteristics and the short-term prognosis after transcatheter tricuspid valve replacement (TTVR) in patients at different stages. Methods: A post-hoc analysis of patients enrolled in the first-in-man and confirmatory study and an investigator-initiated trial of the LuX-Valve Plus system was conducted. Patients with TR who underwent successful TTVR by the LuX-Valve Plus systems were staged according to systemic involvement. The baseline and one-month follow-up results among different stages were compared. Results: A total of 149 patients were included, of whom 23 were in stage 2, 49 were in stage 3, and 77 were in stage 4. Compared with patients in stages 2 and 3, patients in stage 4 had more severe TR (mean vena contracta width: 14.94±4.51 vs. 11.13±4.56 vs. 11.04±3.71 mm, Pvs. 32.35±4.95 vs. 33.56±4.43 mm, P=0.007) and annulus enlargement (tricuspid annulus, 44.87±5.41 vs. 41.54±6.21 vs. 42.13±5.26 mm, P=0.004), higher level of N-terminal pro-brain natriuretic peptide (NT-Pro-BNP) [1,063.50 (541.25, 1,791.25) vs. 631.50 (462.55, 1,409.50) vs. 587.50 (250.55, 908.55) pg/mL, P=0.03], and more extracardiac system damage [such as more lower limbs edema, higher bilirubin level and Model for End-Stage Liver Disease (MELD)-albumin score, lower hemoglobin, platelet count, and estimated glomerular filtration rate (eGFR)]. Regardless of staging, patients generally benefited from TTVR as evidenced by reverse RV remodeling, improved New York Heart Association (NYHA) classification, and improved Kansas City Cardiomyopathy Questionnaire (KCCQ) scores. Patients in stage 4 had a higher incidence of paravalvular leakage after the procedure and all deaths were presented in the stage 4 group. No heart failure readmission was observed during short-term follow-up. Conclusions: The staging of TR syndrome may help to quantify disease severity. Although all patients can gain short-term benefits from TTVR, an early intervention may help to reduce the incidence of complications.
- 1 August 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (8) , 7155-7168
Open AccessShort-term prognosis of patients in different stages of severe tricuspid regurgitation after transcatheter tricuspid-valve replacement
Background: The tricuspid regurgitation (TR) syndrome, based on the extent of cardiac and extracardiac involvement, is a newly proposed staging method to evaluate the progression of TR. This study aimed to explore cardiac structural characteristics and the short-term prognosis after transcatheter tricuspid valve replacement (TTVR) in patients at different stages. Methods: A post-hoc analysis of patients enrolled in the first-in-man and confirmatory study and an investigator-initiated trial of the LuX-Valve Plus system was conducted. Patients with TR who underwent successful TTVR by the LuX-Valve Plus systems were staged according to systemic involvement. The baseline and one-month follow-up results among different stages were compared. Results: A total of 149 patients were included, of whom 23 were in stage 2, 49 were in stage 3, and 77 were in stage 4. Compared with patients in stages 2 and 3, patients in stage 4 had more severe TR (mean vena contracta width: 14.94±4.51 vs. 11.13±4.56 vs. 11.04±3.71 mm, Pvs. 32.35±4.95 vs. 33.56±4.43 mm, P=0.007) and annulus enlargement (tricuspid annulus, 44.87±5.41 vs. 41.54±6.21 vs. 42.13±5.26 mm, P=0.004), higher level of N-terminal pro-brain natriuretic peptide (NT-Pro-BNP) [1,063.50 (541.25, 1,791.25) vs. 631.50 (462.55, 1,409.50) vs. 587.50 (250.55, 908.55) pg/mL, P=0.03], and more extracardiac system damage [such as more lower limbs edema, higher bilirubin level and Model for End-Stage Liver Disease (MELD)-albumin score, lower hemoglobin, platelet count, and estimated glomerular filtration rate (eGFR)]. Regardless of staging, patients generally benefited from TTVR as evidenced by reverse RV remodeling, improved New York Heart Association (NYHA) classification, and improved Kansas City Cardiomyopathy Questionnaire (KCCQ) scores. Patients in stage 4 had a higher incidence of paravalvular leakage after the procedure and all deaths were presented in the stage 4 group. No heart failure readmission was observed during short-term follow-up. Conclusions: The staging of TR syndrome may help to quantify disease severity. Although all patients can gain short-term benefits from TTVR, an early intervention may help to reduce the incidence of complications.
- Open Access
- 1 May 2013
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 45 (5) , 359-367
Exogenous taurine attenuates mitochondrial oxidative stress and endoplasmic reticulum stress in rat cardiomyocytes
Taurine, a conditionally essential amino acid, plays a critical role in cardiovascular function. Here we examined the effect of taurine on mitochondria and endoplasmic reticulum in rat cardiomyocytes during glucose deprivation (GD). Data showed that cell viability, intracellular taurine contents, and taurine transporter expression were decreased during GD. In contrast, an increase in reactive oxygen species and intracellular Ca2+ contents was observed. GD also caused disrupted mitochondrial membrane potential, apoptotic cell death, and dissociation of unfolded protein response (UPR)-relative proteins in cardiomyocytes. Signal transduction analysis showed that Bcl-2 family protein balance was disturbed, caspase-12 was activated and UPR-relative protein levels were up-regulated. Moreover, pre-treatment with 80 mM exogenous taurine attenuated GD effect in cardiomyocytes. Our results suggest that taurine have beneficial effects on inhibiting mitochondria-dependent cell apoptosis and UPR-associated cell apoptosis and might have clinical implications on acute myocardial infarction in future.
- 1 May 2013
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 45 (5) , 359-367
Open AccessExogenous taurine attenuates mitochondrial oxidative stress and endoplasmic reticulum stress in rat cardiomyocytes
Taurine, a conditionally essential amino acid, plays a critical role in cardiovascular function. Here we examined the effect of taurine on mitochondria and endoplasmic reticulum in rat cardiomyocytes during glucose deprivation (GD). Data showed that cell viability, intracellular taurine contents, and taurine transporter expression were decreased during GD. In contrast, an increase in reactive oxygen species and intracellular Ca2+ contents was observed. GD also caused disrupted mitochondrial membrane potential, apoptotic cell death, and dissociation of unfolded protein response (UPR)-relative proteins in cardiomyocytes. Signal transduction analysis showed that Bcl-2 family protein balance was disturbed, caspase-12 was activated and UPR-relative protein levels were up-regulated. Moreover, pre-treatment with 80 mM exogenous taurine attenuated GD effect in cardiomyocytes. Our results suggest that taurine have beneficial effects on inhibiting mitochondria-dependent cell apoptosis and UPR-associated cell apoptosis and might have clinical implications on acute myocardial infarction in future.
- 1 April 2013
- Published by Elsevier in Atherosclerosis
- Vol. 228 (2) , 438-442
High PLTP activity is associated with depressed left ventricular systolic function
- 1 April 2013
- Published by Elsevier in Atherosclerosis
- Vol. 228 (2) , 438-442
High PLTP activity is associated with depressed left ventricular systolic function
- Open Access
- 26 April 2011
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 8 (1) , 25
Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans
Sphingomyelin (SM) is an abundant phospholipid in cell membranes and in lipoproteins. In human plasma, SM is mainly found in atherogenic lipoproteins; therefore, higher levels of SM may promote atherogenesis. We investigated the relations between plasma SM levels and the presence of angiographic coronary heart disease (CHD) and left ventricular systolic dysfunction. We studied 732 patients referred for coronary angiography. Median SM levels were higher among patients with CHD and in those with LV systolic dysfunction (LVEF<50%) than in patients without CHD or LV dysfunction. SM levels were significantly correlated with fibrinogen levels, diabetes, apoB, and triglyceride levels. On multivariate analyses, higher median SM levels were associated with a higher risk of CHD and lower LV ejection fraction. The pro-atherogenic property of plasma SM might be related to 1) CHD; 2) LV systolic dysfunction; and 3) metabolism of apoB-containing or triglyceride-rich lipoproteins.
- 26 April 2011
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 8 (1) , 25
Open AccessImpact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans
Sphingomyelin (SM) is an abundant phospholipid in cell membranes and in lipoproteins. In human plasma, SM is mainly found in atherogenic lipoproteins; therefore, higher levels of SM may promote atherogenesis. We investigated the relations between plasma SM levels and the presence of angiographic coronary heart disease (CHD) and left ventricular systolic dysfunction. We studied 732 patients referred for coronary angiography. Median SM levels were higher among patients with CHD and in those with LV systolic dysfunction (LVEF<50%) than in patients without CHD or LV dysfunction. SM levels were significantly correlated with fibrinogen levels, diabetes, apoB, and triglyceride levels. On multivariate analyses, higher median SM levels were associated with a higher risk of CHD and lower LV ejection fraction. The pro-atherogenic property of plasma SM might be related to 1) CHD; 2) LV systolic dysfunction; and 3) metabolism of apoB-containing or triglyceride-rich lipoproteins.
- Open Access
- 30 November 2009
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 6 (1) , 49
Plasma PLTP activity is inversely associated with HDL-C levels
Phospholipid transfer protein (PLTP) is an important modulator of lipoprotein metabolism, including interparticle phospholipid transfer, remodeling of HDL, cholesterol and phospholipid efflux from peripheral tissues, and the production of hepatic VLDL. PLTP also plays an important role in inflammation and oxidative stress. Accordingly, PLTP has been implicated in the development of atherosclerosis. In this study, we evaluated the association between PLTP activity and lipoprotein metabolism in a Chinese patients cohort with or without coronary heart disease (CHD group n = 407, control group n = 215), the PLTP activity was measured and PLTP genotyping was screened for sequence anomalies by PCR. We found that human plasma PLTP activity was negatively associated with plasma HDL and apoA-I levels, and positively associated with plasma TG, apoB and apoE levels. We also found that PLTP rs2294213 polymorphism was tended to be associated with increased plasma PLTP activity.
- 30 November 2009
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 6 (1) , 49
Open AccessPlasma PLTP activity is inversely associated with HDL-C levels
Phospholipid transfer protein (PLTP) is an important modulator of lipoprotein metabolism, including interparticle phospholipid transfer, remodeling of HDL, cholesterol and phospholipid efflux from peripheral tissues, and the production of hepatic VLDL. PLTP also plays an important role in inflammation and oxidative stress. Accordingly, PLTP has been implicated in the development of atherosclerosis. In this study, we evaluated the association between PLTP activity and lipoprotein metabolism in a Chinese patients cohort with or without coronary heart disease (CHD group n = 407, control group n = 215), the PLTP activity was measured and PLTP genotyping was screened for sequence anomalies by PCR. We found that human plasma PLTP activity was negatively associated with plasma HDL and apoA-I levels, and positively associated with plasma TG, apoB and apoE levels. We also found that PLTP rs2294213 polymorphism was tended to be associated with increased plasma PLTP activity.
- 1 April 2007
- Vol. 35 (4) , 344-9
[In vivo cardiac magnetic resonance imaging of superparamagnetic iron oxides-labeled mesenchymal stem cells in swines].
To explore the feasibility of magnetic resonance imaging (MR) on detecting transplanted nanometer small superparamagnetic iron oxides (SPIO) labeled mesenchymal stem cells (MSCs) in swine model with acute myocardial infarction (MI). MSCs isolated from swine were incubated with nanometer SPIO for 24 hours and the third-passage MSCs were labeled with DNA dye 4'-6-diamidino-2-phenylindole (DAPI) and aliphatic red fluorescent dye PKH(26)-GL. Presence of small particles of SPIO in MSCs was assessed by Prussian Blue staining and electron microscopy. Three animals in each group received SPIO-labeled MSCs (5 x 10(5); 1 x 10(6); 2 x 10(6)) and MSCs without SPIO (1 x 10(6)) injections into the infarcted myocardium approximately 1 hour following left anterior descending coronary artery. MRI (1.5-T) was performed 20 to 24 hours post infarction in all animals and the animals were subsequently sacrificed for histology 1 hour post MRI. In vitro Prussian Blue staining and electron microscopy examination revealed numerous iron particles in the cytoplasm of MSCs. Low signal intensity spots with the scanning T(2)(*)WI-Flash 2d sequence were detected in all SPIO-MSCs but not in SPIO-negative-MSCs injected myocardial sites in vivo with the clinical 1.5 T scanner. Prussian blue, DAPI and PKH(26) positive cells were detected histologically in sections corresponding to low signal intensity spots area shown on MRI. Magnetically labeled MSCs transplanted in myocardial ischemia area of swine can be visualized in vivo with a clinical 1.5-T MRI and could be used for tracking SPIO-MSCs clinically.
- 1 April 2007
- Vol. 35 (4) , 344-9
[In vivo cardiac magnetic resonance imaging of superparamagnetic iron oxides-labeled mesenchymal stem cells in swines].
To explore the feasibility of magnetic resonance imaging (MR) on detecting transplanted nanometer small superparamagnetic iron oxides (SPIO) labeled mesenchymal stem cells (MSCs) in swine model with acute myocardial infarction (MI). MSCs isolated from swine were incubated with nanometer SPIO for 24 hours and the third-passage MSCs were labeled with DNA dye 4'-6-diamidino-2-phenylindole (DAPI) and aliphatic red fluorescent dye PKH(26)-GL. Presence of small particles of SPIO in MSCs was assessed by Prussian Blue staining and electron microscopy. Three animals in each group received SPIO-labeled MSCs (5 x 10(5); 1 x 10(6); 2 x 10(6)) and MSCs without SPIO (1 x 10(6)) injections into the infarcted myocardium approximately 1 hour following left anterior descending coronary artery. MRI (1.5-T) was performed 20 to 24 hours post infarction in all animals and the animals were subsequently sacrificed for histology 1 hour post MRI. In vitro Prussian Blue staining and electron microscopy examination revealed numerous iron particles in the cytoplasm of MSCs. Low signal intensity spots with the scanning T(2)(*)WI-Flash 2d sequence were detected in all SPIO-MSCs but not in SPIO-negative-MSCs injected myocardial sites in vivo with the clinical 1.5 T scanner. Prussian blue, DAPI and PKH(26) positive cells were detected histologically in sections corresponding to low signal intensity spots area shown on MRI. Magnetically labeled MSCs transplanted in myocardial ischemia area of swine can be visualized in vivo with a clinical 1.5-T MRI and could be used for tracking SPIO-MSCs clinically.
- Open Access
- 1 October 2006
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 119 (20) , 1689-1694
Relationship between hs-CRP, proMMP-1, TIMP-1 and coronary plaque morphology: intravascular ultrasound study
Rupture of unstable plaque with subsequent thrombus formation is the common pathophy-siological substrate of the acute coronary syndrome (ACS). It is of potential significance to explore the blood indexes predicting plaque characteristics. Little studies have focused on this field. Therefore we investigated the relationship between hypersensitive C-reactive protein (hs-CRP), pro-matrix metalloproteinase-1 (proMMP-1), tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) and coronary plaque morphology. Intravascular ultrasound (IVUS) examination was done in 152 patients with confirmed coronary heart disease before percutaneous coronary intervention from February 2003 to July 2005. Plasma samples of arterial blood were collected prior to the procedure. The level of hs-CRP, proMMP-1 and TIMP-1 were respectively measured by enzyme-linked immunosorbent assay (ELISA). Unstable and ruptured plaque were found more frequently in patients with acute myocardial infarction and unstable angina. External elastic membrane cross-sectional area (EEM CSA), plaque area, lipid pool area and plaque burden were significantly larger in ruptured and unstable plaque group. Positive remolding, thinner fabric-cap, smaller minimal lumen cross-sectional area (MLA), dissection and thrombus were significantly more frequent in ruptured and unstable plaque group. The levels of plasma hs-CRP, proMMP-1 and TIMP-1 were higher in ruptured plaque group. hs-CRP>8.94 mg/L was used to predict ruptured plaque with a ROC curve area of 0.76 [95% confidence interval (CI), 67.0%—85.8%], sensitivity of 71.8%, specificity of 77.0% and accuracy of 69.2% (P0.12 ng/ml with a ROC curve area of 0.69 [95% CI, 58.2%-80.2%], sensitivity of 69.2%, specificity of 75.2% and accuracy of 66.2% (P83.45 ng/ml with a ROC curve area of 0.67 [95% CI, 56.2%—78.3%], sensitivity of 66.7%, specificity of 61.9% and accuracy of 66.2% (P<0.01). The plaque characteristics correlate with the clinical presentation. The elevation of hs-CRP, proMMP-1 and TIMP-1 are related to the plaque instability and rupture.
- 1 October 2006
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 119 (20) , 1689-1694
Open AccessRelationship between hs-CRP, proMMP-1, TIMP-1 and coronary plaque morphology: intravascular ultrasound study
Rupture of unstable plaque with subsequent thrombus formation is the common pathophy-siological substrate of the acute coronary syndrome (ACS). It is of potential significance to explore the blood indexes predicting plaque characteristics. Little studies have focused on this field. Therefore we investigated the relationship between hypersensitive C-reactive protein (hs-CRP), pro-matrix metalloproteinase-1 (proMMP-1), tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) and coronary plaque morphology. Intravascular ultrasound (IVUS) examination was done in 152 patients with confirmed coronary heart disease before percutaneous coronary intervention from February 2003 to July 2005. Plasma samples of arterial blood were collected prior to the procedure. The level of hs-CRP, proMMP-1 and TIMP-1 were respectively measured by enzyme-linked immunosorbent assay (ELISA). Unstable and ruptured plaque were found more frequently in patients with acute myocardial infarction and unstable angina. External elastic membrane cross-sectional area (EEM CSA), plaque area, lipid pool area and plaque burden were significantly larger in ruptured and unstable plaque group. Positive remolding, thinner fabric-cap, smaller minimal lumen cross-sectional area (MLA), dissection and thrombus were significantly more frequent in ruptured and unstable plaque group. The levels of plasma hs-CRP, proMMP-1 and TIMP-1 were higher in ruptured plaque group. hs-CRP>8.94 mg/L was used to predict ruptured plaque with a ROC curve area of 0.76 [95% confidence interval (CI), 67.0%—85.8%], sensitivity of 71.8%, specificity of 77.0% and accuracy of 69.2% (P0.12 ng/ml with a ROC curve area of 0.69 [95% CI, 58.2%-80.2%], sensitivity of 69.2%, specificity of 75.2% and accuracy of 66.2% (P83.45 ng/ml with a ROC curve area of 0.67 [95% CI, 56.2%—78.3%], sensitivity of 66.7%, specificity of 61.9% and accuracy of 66.2% (P<0.01). The plaque characteristics correlate with the clinical presentation. The elevation of hs-CRP, proMMP-1 and TIMP-1 are related to the plaque instability and rupture.
- 22 June 2006
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 99 (4) , 1132-1147
Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: Single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source
A variety of adult stem cells have been used to transplant into the infarcted (MI) heart, however, comparative studies are lacking to show more suitable source of cells for transplantation. We have identified a single non‐hematopoietic mesenchymal stem cell subpopulation (snMSCs) isolated from human bone marrow and clonally purified, that over 99% of them expressed MSC marker proteins and cardiomyocyte marker proteins when induction in vitro. We also compared the effects of the snMSCs with unpurified MSC (uMSCs), mononuclear cells (BMMNCs), or peripheral blood mononuclear cells (PBMNCs) on myocardial repair after induction of MI in rats. Ninety days later, we observed a better cardiac function assessed by ejection fraction, fraction of shortening and lung wet/dry weight ratios, less remodeling of left ventricle (LV), lower collagen density in the LV, and more vessels in the ischemic wall in the snMSCs transplantation group than in other cell‐transplanted groups. Furthermore, the transplanted cells expressing cardiomyocyte specific proteins or vascular endothelial cell marker proteins were more in the snMSCs group than in other ones. We conclude that transplantation with single clonally purified MSCs seems to be more beneficial to the cardiac repair than with other stem cells after MI. J. Cell. Biochem. 99: 1132–1147, 2006.
- 22 June 2006
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 99 (4) , 1132-1147
Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: Single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source
A variety of adult stem cells have been used to transplant into the infarcted (MI) heart, however, comparative studies are lacking to show more suitable source of cells for transplantation. We have identified a single non‐hematopoietic mesenchymal stem cell subpopulation (snMSCs) isolated from human bone marrow and clonally purified, that over 99% of them expressed MSC marker proteins and cardiomyocyte marker proteins when induction in vitro. We also compared the effects of the snMSCs with unpurified MSC (uMSCs), mononuclear cells (BMMNCs), or peripheral blood mononuclear cells (PBMNCs) on myocardial repair after induction of MI in rats. Ninety days later, we observed a better cardiac function assessed by ejection fraction, fraction of shortening and lung wet/dry weight ratios, less remodeling of left ventricle (LV), lower collagen density in the LV, and more vessels in the ischemic wall in the snMSCs transplantation group than in other cell‐transplanted groups. Furthermore, the transplanted cells expressing cardiomyocyte specific proteins or vascular endothelial cell marker proteins were more in the snMSCs group than in other ones. We conclude that transplantation with single clonally purified MSCs seems to be more beneficial to the cardiac repair than with other stem cells after MI. J. Cell. Biochem. 99: 1132–1147, 2006.
- 1 December 2004
- Published by Elsevier in Atherosclerosis
- Vol. 177 (2) , 263-268
Upregulation of lectinlike oxidized low-density lipoprotein receptor-1 expression contributes to the vein graft atherosclerosis: modulation by losartan
- 1 December 2004
- Published by Elsevier in Atherosclerosis
- Vol. 177 (2) , 263-268
Upregulation of lectinlike oxidized low-density lipoprotein receptor-1 expression contributes to the vein graft atherosclerosis: modulation by losartan